Hofseth Biocare ASA
OSE:HBC
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.405
2.82
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HBC stock under the Base Case scenario is 4.33 NOK. Compared to the current market price of 1.43 NOK, Hofseth Biocare ASA is Undervalued by 67%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Hofseth Biocare ASA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for HBC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Hofseth Biocare ASA
Balance Sheet Decomposition
Hofseth Biocare ASA
Current Assets | 135.8m |
Cash & Short-Term Investments | 25.3m |
Receivables | 27m |
Other Current Assets | 83.5m |
Non-Current Assets | 249.7m |
Long-Term Investments | 51.3m |
PP&E | 152.7m |
Intangibles | 45.7m |
Current Liabilities | 155.5m |
Accounts Payable | 70.5m |
Other Current Liabilities | 85.1m |
Non-Current Liabilities | 91.8m |
Long-Term Debt | 92.5m |
Other Non-Current Liabilities | -687k |
Earnings Waterfall
Hofseth Biocare ASA
Revenue
|
221.9m
NOK
|
Cost of Revenue
|
-158.3m
NOK
|
Gross Profit
|
63.6m
NOK
|
Operating Expenses
|
-184m
NOK
|
Operating Income
|
-120.4m
NOK
|
Other Expenses
|
-747k
NOK
|
Net Income
|
-121.2m
NOK
|
Free Cash Flow Analysis
Hofseth Biocare ASA
NOK | |
Free Cash Flow | NOK |
HBC Profitability Score
Profitability Due Diligence
Hofseth Biocare ASA's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Hofseth Biocare ASA's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
HBC Solvency Score
Solvency Due Diligence
Hofseth Biocare ASA's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Score
Hofseth Biocare ASA's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HBC Price Targets Summary
Hofseth Biocare ASA
Dividends
Current shareholder yield for HBC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Hofseth Biocare ASA engages in the development, marketing, and sale of biomarine ingredients. The company is headquartered in Alesund, More Og Romsdal and currently employs 63 full-time employees. The company went IPO on 2011-12-02. The Company’s business is development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. Its main products are Salmon protein hydrolysate (ProGo), which is a protein for sports, endurance, and recovery powders; Fresh, all-natural salmon oil (OmeGo) that has a full spectrum of omega fatty acids, including EPA, DHA and DPA, totaling 21 different fatty acids; Calcium bone powder (CalGo) is a natural marine collagenic bone powder and CollaGo is a Collagen Peptide powder optimised to improve the beauty of hair, skin and nails. Hofseth BioCare's headquarters are in Aalesund with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.
Contact
IPO
Employees
Officers
The intrinsic value of one HBC stock under the Base Case scenario is 4.33 NOK.
Compared to the current market price of 1.43 NOK, Hofseth Biocare ASA is Undervalued by 67%.